Liu R - Search Results

1

N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21^cip1/waf1/CDK2-Cyclin E1 axis-mediated cell cycle transition.

Liu R, Miao J, Jia Y, Kong G, Hong F, Li F, Zhai M, Zhang R, Liu J, Xu X, Wang T, Liu H, Hu J, Yang Y, He A. Liu R, et al. Among authors: liu j, liu h. Oncogene. 2023 May;42(20):1607-1619. doi: 10.1038/s41388-023-02675-w. Epub 2023 Apr 3. Oncogene. 2023. PMID: 37012388 Free PMC article.

2

Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations.

Liu R, Wang X, Shen Y, He A. Liu R, et al. Mol Biol Rep. 2021 Mar;48(3):2713-2727. doi: 10.1007/s11033-021-06247-7. Epub 2021 Mar 11. Mol Biol Rep. 2021. PMID: 33704659 Review.

3

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.

Liu R, Shen Y, Hu J, Wang X, Wu D, Zhai M, Bai J, He A. Liu R, et al. Front Oncol. 2021 Nov 4;11:731957. doi: 10.3389/fonc.2021.731957. eCollection 2021. Front Oncol. 2021. PMID: 34804925 Free PMC article.

4

Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies.

Liu R, Gao D, Lv Y, Zhai M, He A. Liu R, et al. BMC Endocr Disord. 2022 Jan 25;22(1):29. doi: 10.1186/s12902-022-00939-2. BMC Endocr Disord. 2022. PMID: 35073877 Free PMC article.

5

Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.

Liu R, Jia Y, Kong G, He A. Liu R, et al. J Cancer Res Clin Oncol. 2022 Sep;148(9):2215-2230. doi: 10.1007/s00432-022-04134-7. Epub 2022 Jun 28. J Cancer Res Clin Oncol. 2022. PMID: 35763107 Review.

6

A comprehensive analysis of coagulopathy during anti-B cell maturation antigen chimeric antigen receptor-T therapy in multiple myeloma, a retrospective study based on LEGEND-2.

Liu R, Lv Y, Hong F, Zhao W, Lei B, Liu J, Zhang W, He A, Wang F. Liu R, et al. Among authors: liu j. Hematol Oncol. 2023 Oct;41(4):704-717. doi: 10.1002/hon.3155. Epub 2023 Apr 25. Hematol Oncol. 2023. PMID: 37186314

7

PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6.

Jia Y, Yu X, Liu R, Shi L, Jin H, Yang D, Zhang X, Shen Y, Feng Y, Zhang P, Yang Y, Zhang L, Zhang P, Li Z, He A, Kong G. Jia Y, et al. Among authors: liu r. Cell Death Dis. 2023 Aug 9;14(8):512. doi: 10.1038/s41419-023-06036-z. Cell Death Dis. 2023. PMID: 37558663 Free PMC article.

8

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.

Jia Y, Liu R, Shi L, Feng Y, Zhang L, Guo N, He A, Kong G. Jia Y, et al. Among authors: liu r. BMC Cancer. 2023 Sep 12;23(1):859. doi: 10.1186/s12885-023-11371-7. BMC Cancer. 2023. PMID: 37700273 Free PMC article.

9

Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia.

Xu X, Liu R, He A, Wang F. Xu X, et al. Among authors: liu r. Hematology. 2023 Dec;28(1):2265206. doi: 10.1080/16078454.2023.2265206. Epub 2023 Oct 5. Hematology. 2023. PMID: 37796109 Free article.

10

[Alteration and significance of serum lipid levels and nutritional status during BCMA-CAR-T-cell therapy in patients with refractory or relapsed multiple myeloma: a retrospective study based on LEGEND-2].

Xu XZ, Liu R, Zhao WH, Yang Y, Liu J, Zhang WG, Bai J, He AL. Xu XZ, et al. Among authors: liu j, liu r. Zhonghua Xue Ye Xue Za Zhi. 2023 Oct 14;44(10):838-844. doi: 10.3760/cma.j.issn.0253-2727.2023.10.008. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38049336 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,841 results

Search Page

Filters